Tinatox, 50 g

Upute za korištenje Tinatox, 50 g

Important notes (compulsory information):

Tinatox 1% cream. Active substance: Tolnafter. Areas of application: for the external treatment of pilot diseases of the skin (Dermatomycoses) caused by skin mushrooms (dermatophytes).

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Tinatox 1% cream for use on the skin
Active substance: Tolnaftat

Read the entire leaflet carefully because it contains important information for you. This medicine is available without prescription. However, in order to achieve the best possible treatment success, Tinatox Cream needs to be used properly.

• Lift the package leaflet. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If your complaints worse or no improvement occurs, you must definitely visit a doctor.
• If one of the listed side effects you significantly affect it or notice side effects that are not specified in this information information, please inform your doctor or pharmacist.

The leaflet includes:

1. What is Tinatox Cream and Wofiir Is it used?
2. What do you need to keep in mind before using Tinatox Cream?
3. How is Tinatox creme to apply?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. How to keep Tinatox cream?
6. ADDITIONAL INFORMATION

1. What is Tinatox cream and wofir is applied?

The active ingredient Tolnaftat contained in Tinatox Cream belongs to the group of antimycotics and is used for the external treatment of certain pilot diseases of the skin (densatomycoses). Tinatox cream becomes the external treatment of hinge diseases of the skin (dermatomycoses) caused by skin mushrooms (Dermatophytes), applied.

2. What do you need to keep in mind before using Tinatox Cream?

Tinatox cream must not be used if they are hypersensitive (allergic) against TolnaFat or any of the other ingredients of Tinatox cream.

Take special care with the use of Tinatox Cream:
Tinatox Cream is not suitable for an application on the eye. Only for external use. Tinatox Cream is effective in diseases caused by dermatophytes. For dermatomycoses that cause other causes (e.g., sprout and yeast) or who do not improve under treatment with Tolnaftat, the doctor must be visited.

When using Tinatox cream with other medicines:
Interactions with other means are not known from Tinatox Cream. Please inform your doctor or pharmacist if you take / use other medicines or recently taken / applied, even if it is non-prescription medicines.

When using Tinatox cream together with food and beverages:
Not applicable.

Pregnancy Lind Latency:
The application of Tinatox cream should be in pregnancy and lactation only after consultation with your doctor. Tinatox cream must not be used in the chest range during breast-feeding to avoid direct contact of the infant with the active ingredient,

Driveion Lind the use of machines:
There are no experience in the impairment of ability to drive and the ability to serve machines.

Important information about certain other ingredients of Tinatox Cream:
Cetylstearyl alcohol can locally limited skin irritation (e.g. Contact Denatitis). Sorbic acid can cause localized skin irritation (e.g., contact dermatitis.

3. How is Tinatox creme to apply?

Always use Tinatox Cream exactly as directed in this packing side. Please ask your doctor or pharmacist if you do not quite Si am. Unless otherwise prescribed, Tinatox cream is applied for 1 to 2 times a day on the infested skin and smashed slightly. The diseased skin section is previously thoroughly cleaned and carefully dried. Treatment should be continued for at least 14 days after decays of complaints to avoid relapses.

If you have used a larger amount of TinatoxCreme as you should:
If you accidentally have exceeded the recommended dose or have used the solution too frequently, no side effects are generally expected.

If you forget the application of Tinatox Cream:
If you have forgotten the application of the cream, you continue to apply the cream as usual as usual.

If you cancel the application of Tinatox Cream:
Do not terminate the application with the cream, unless you suspect a serious side effect. In this case, you should immediately consult with your doctor.

If you have further questions about the application of the medicine, ask your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, Tinatox can have side effects that need not occur with each treated. The assessment of side effects is based on the following frequency information:

The frequency information on side effects is based on the following categories:
Very often:	more than 1 treated from 10
Frequently:	1 to 10 treated from 100
Occasionally:	1 to 10 treated from 1 000
Rarely:	1 to 10 treated from 10 000
Very rare:	less than 1 treated from 10 000
Not known:	Frequency on the basis of the available data does not estimate.

Occasionally, slight skin irritation can occur. Please inform your doctor or pharmacist if the experienced level will significantly affect it or notice side effects,
which are not specified in this document formation.

5. How to keep Tinatox cream?

Store drug out of reach of children. You must not use the medicinal product after the expiry date specified on the folding box and the TUBE.

Note on durability after a break:
The usability time after a break of the tube is 12 Months.

6. Further information

What contains Tinatox Cream:
The active ingredient is: Tolnafter. 100 g of cream contains 1 g of Tolnaftat. The other ingredients are: cetylstearyl alcohol (ph.eur.), Medium-chain triglycerides, alkyl (C14-C L8) (tetradecanoate, palmitate, stearate), glycerol, isopropyl myristate (ph.eur.), Macrogolcetylstearyl ether (Ph. EUR.), Glycerol monostearate 40-55%, Lactic acid, sorbic acid (ph.eur.), Purified water.

How to look for Tinatox cream and content of the pack:
White, homogeneous cream. Original pack to 50 g cream (N2).

Pharmaceutical entrepreneur and manufacturer:
Leyh-Pharma GmbH
In Baierstal 6
D-98596 Trusetal
Fon: +49 (0) 36840/80009
Fax: +49 (0) 36840/80019

This information information was last revised in May 2012.

Source: Information of the leaflet
Status: 02/2016